Bioleaders Corporation (142760) — Long-term Investment Intensity

Latest as of September 2019: 0.5%

Bioleaders Corporation (142760) has a Long-term Investment Intensity of 0.5% as of September 2019. Long-term investments of ₩750.46 Million represent 0.5% of total assets of ₩153.31 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Bioleaders Corporation total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.5%
LT Investments / Total Assets

Long-term Investments

₩750.46 Million
KRW

Total Assets

₩153.31 Billion
KRW

Country

Korea
KQ

Bioleaders Corporation Long-term Investment Intensity (2016–2018)

This chart shows how Bioleaders Corporation's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 0.5%, reflecting long-term investments of ₩750.46 Million against total assets of ₩153.31 Billion KRW. Explore 142760 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Bioleaders Corporation (2016–2018)

The table below presents the year-by-year Long-term Investment Intensity for Bioleaders Corporation from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 142760 company net worth.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2018 1.1% ₩1.75 Billion ₩153.29 Billion ▼ -1.0 pp
2017 2.1% ₩786.11 Million ₩37.58 Billion ▲ +1.9 pp
2016 0.2% ₩43.20 Million ₩21.61 Billion
pp = percentage points